Date Document
10/12/2004 Notice Under Section 708A(5)
08/12/2004 Letter to Shareholders & Optionholders
06/12/2004 Notice of General Meeting
03/12/2004 Appendix 3B - Issue & Conversion of Securities
02/12/2004 Letter to Shareholders & Optionholders
01/12/2004 US Approval of FerriScan Closer with FDA 510(k) submission
26/11/2004 Results of AGM
25/11/2004 AGM Presentation
25/11/2004 Company Update Letter to Optionholders
25/11/2004 Company Update Letter to Shareholders
23/11/2004 TGA to List FerriScan
23/11/2004 $1 Million Placement
12/11/2004 Appendix 3B - Issue & conversion of securities
05/11/2004 New Liver Test to be Developed following BIF Grant
03/11/2004 Response to ASX Query re: Appendix 4C
29/10/2004 Commitments Test Entity - First Quarter Report
25/10/2004 Annual Report & Notice of Annual General Meeting
30/09/2004 Annual Report
31/08/2004 Preliminary Final Report
04/08/2004 Notice of proposed sale of unmarketable parcels of shares
30/07/2004 Commitments Test Entity - Fourth Quarter Report
20/07/2004 FerriScan Inv recognized for Excellence in Breakthrough Tech
12/07/2004 Change of Director's Interest Notice x4
12/07/2004 Appendix 3B - Incentive Option Scheme
02/06/2004 Transfer of Share Registry
18/05/2004 Change of Director's Interest Notice
17/05/2004 Response to ASX Query re Appendix 4C
14/05/2004 Appointment of Dr James Williams as Chief Executive Officer
13/05/2004 Results of Meeting
29/04/2004 Commitments Test Entity - Third Quarter Report
15/04/2004 Appointment of Joint Company Secretary
13/04/2004 TGA Submission for Ferriscan lodged
05/04/2004 Letter to Shareholders: Important Commercial Success
05/04/2004 IVB Signs Agreement with Novartis Pharma
02/04/2004 Appendix 3B - Exercise of options
31/03/2004 TGA Submission on track for 7/4/04 Lodgment
26/03/2004 Notice of General Meeting
24/03/2004 Comm Collaboration to introduce the Ferriscan test in UK
23/03/2004 Company Update - Newsletter to Shareholders
12/03/2004 Letter to Shareholders: Share Purchase Plan/Appendix 3B
27/02/2004 Half Yearly Report & Half Year Accounts
25/02/2004 Distribution schedule of options
25/02/2004 Top 20 holders of new options
25/02/2004 Appendix 3B - Exercise of options
27/01/2004 Commitments Test Entity - Second Quarter Report
07/01/2004 App 3B - Satisfy co. obligations re Implementation Agreement
06/01/2004 Response to ASX Query re: Share Price